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Abstract
Genetic and chemical biology screens of C. elegans have been of enormous benefit in providing fundamental insight into
neural function and neuroactive drugs. Recently the exploitation of microfluidic devices has added greater power to this
experimental approach providing more discrete and higher throughput phenotypic analysis of neural systems. Here we
make a significant addition to this repertoire through the design of a semi-automated microfluidic device, NeuroChip, which
has been optimised for selecting worms based on the electrophysiological features of the pharyngeal neural network. We
demonstrate this device has the capability to sort mutant from wild-type worms based on high definition extracellular
electrophysiological recordings. NeuroChip resolves discrete differences in excitatory, inhibitory and neuromodulatory
components of the neural network from individual animals. Worms may be fed into the device consecutively from a
reservoir and recovered unharmed. It combines microfluidics with integrated electrode recording for sequential trapping,
restraining, recording, releasing and recovering of C. elegans. Thus mutant worms may be selected, recovered and
propagated enabling mutagenesis screens based on an electrophysiological phenotype. Drugs may be rapidly applied
during the recording thus permitting compound screening. For toxicology, this analysis can provide a precise description of
sub-lethal effects on neural function. The chamber has been modified to accommodate L2 larval stages showing
applicability for small size nematodes including parasitic species which otherwise are not tractable to this experimental
approach. We also combine NeuroChip with optogenetics for targeted interrogation of the function of the neural circuit.
NeuroChip thus adds a new tool for exploitation of C. elegans and has applications in neurogenetics, drug discovery and
neurotoxicology.
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Introduction
Genetic and chemical biology screens on the nematode
Caenorhabditis elegans have provided fundamental insight into neural
function encompassing key aspects of neurosecretion, synapse
formation and regeneration [1–3]. These approaches are based on
visual observation to delineate phenotypes. Recently microfluidic
devices have been designed that facilitate C. elegans screens by
allowing controlled immobilization [4–7], high resolution imaging
[5,6,8–10] and behavioural or developmental observation [11–
19]. Not only has this enabled high-throughput studies [20–24]
but it has also delineated new phenotypes by virtue of refined
analysis [25].
The ability to screen for C. elegans synaptic phenotypes based on
an electrophysiological signature would add a new level of
refinement to probing synaptic function. Indeed mutations that
alter synaptic transmission are not always associated with an
obvious morphological or behavioural phenotype [26]. Typically,
electrophysiological recordings, particularly in C. elegans, are
technically challenging and time-consuming and thus not suited
to screening approaches. However, the C. elegans pharyngeal
neural network provides an opportunity to circumvent this. Its
activity, the electropharyngeogram (EPG), can be captured by a
suction electrode placed over the mouth of the intact worm [27].
This records the electrical signal of the rhythmically pumping
pharynx to monitor frequency and duration of the contraction-
relaxation cycle. Moreover, fine features of the EPG are
synaptically driven events from excitatory and inhibitory neurones
and can report on neural signalling and neuromodulatory
components of the circuit [27–31]. Recently microfluidic devices
have been developed which replace the need for manual trapping
and conventional microelectrodes [32–34] one of which has made
progress towards resolving synaptically driven events in the EPG
by adopting a new two layer design [34]. Here we report the
development of a device based on this principle which we have
called ‘NeuroChip’ because it yields high resolution EPG
recordings in which the aforementioned synaptic events can be
reliably detected in recordings of low level basal activity and
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during periods of rapid, stimulated activity. It has been optimised
for trapping worms in the correct orientation, mimicking the shape
of a conventional microelectrode aperture and for rapid drug or
chemical application. It also incorporates an integral electrode to
facilitate ease of use. We demonstrate selection of mutant from
wild-type worms on the basis of their distinctive electrophysiolog-
ical signature. The device is further configured to allow
optogenetic interrogation of the neural network. Taken together
these features of NeuroChip endow it with the capability to select
discrete electrophysiological synaptic and neuromuscular pheno-
types from mixed populations of worms, a property commensurate
with it performing as a robust platform for genetic and chemical
biology screens with potential to deliver new insight into neural
function and to facilitate drug discovery.
Materials and Methods
Design of the NeuroChip
To achieve a high quality EPG signal, a robust and electrically
tight seal around the worm’s head is required. In order to design a
trapping channel that mimicked the capability of the conventional
electrode to extract discrete neural components of the waveform
the fabrication of the microfluidic device was optimised over
several iterations. The key steps are indicated in Fig. 1B. The
incorporation of a soft under-layer and an additional procedure to
form semi-cylindrical channels so that the microfluidic chamber
has a rounded ‘ceiling’ ultimately permitted the robust capture of
EPG signals that were indistinguishable from those obtained using
conventional glass microelectrodes (Fig. 1 B, C; Fig. 2 A). Before
this optimisation the amplitude and waveform were similar to that
reported with the device designed by Lockery et al (Fig. 1C, first
recording) [33].
Consistent precise placement of the worm in the trap facilitates
reproducibility of the recorded EPG waveforms. The optimum
size for trapping a one day old adult hermaphrodite was
determined by fabricating a range of different channel dimensions
ranging from 9 mm65 mm615 mm to 40 mm612 mm630 mm
(width6height6length). Young adult worms (L4+1 day) were
chosen. The design was further modified to capture L2 larvae a
distinct advantage over conventional recordings as these are
extremely difficult to perform on these small (less than 500 mm),
very motile worms.
The device was designed in two layers of PDMS (polydimethyl-
siloxane). The top layer is the microfluidic layer, which consists of
the trapping channel and several bypass channels (green in
Fig. 2B). The bottom layer also contains the valve control layer
(red in Fig. 2B) with four pneumatic micro-valves [35–37]. The
Figure 1. A comparison of different preliminary designs of microfluidic trapping channel and the resulting electropharyngeogram
(EPG) signal. A. An example of a single pharyngeal pump recording, EPG, obtained using a conventional suction microelectrode placed over the
mouth of the worm using a cut head preparation. This waveform depicts three phases: E (e, E), P, and R (R, r) phase which report on the activity of the
neural circuit that regulates the worm’s feeding behaviour (see text). B. Evolution of the shape of the aperture and C. the corresponding EPG signals.
The first signal is obtained from a single layer chip and the aperture which traps the worm’s anterior is square, which is similar to the device described
by Lockery et al. [33]. The signal in the middle is taken from a single layer chip with semi-circular aperture, which is more similar to the shape of the
worm. The last example of an EPG signal is recorded from a two-layer chip with semi-circular shape aperture. The softer base provides a better seal
and thus generates a larger amplitude EPG and improved resolution of subcomponents of the waveform reporting neural activity. Each phase and
feature of the EPG are of greater magnitude in this last waveform. All the features are marked with red circles.
doi:10.1371/journal.pone.0064297.g001
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bypass channels are 50 mm wider than the dimension of young
adult (L4+1 day) C. elegans and are used to transport worms and
drugs. The device is designed so that worms can be loaded into the
channel in solution individually (via a pipette tip inserted into the
PMDS) or from a reservoir attached to the chip. Individual worms
enter the channel from the inlet marked ‘worm port’ (Fig. 2C). In
Figure 2. Conventional and microfluidic methods for extracellular electrophysiological recording from the C. elegans pharyngeal
nervous system. A. Schematic of conventional microelectrode EPG recording setup. B. Photograph of the microfluidic NeuroChip. Channels filled
with food dye: Green flow layer; red control layer. C & D. Diagram of the NeuroChip. It is a two-layer structure: the blue layer is the microfluidic region
processing worms and delivery of drugs. Trapping region (red circled) is magnified in D, showing the trapped worm’s head. The red square is the
micro-pillar region which facilitates correct orientation of the worm. The white layer is the pneumatic control layer (V1, V2, V3 and V4 indicate Valve 1,
2, 3 and 4 respectively). The three black squares are the microelectrodes. E. SEM image of the trapping region. F. Photograph of a worm trapped in
the device. The worm is trapped at the front part of its corpus. G. Addition of a wide perforated chamber alongside the worm to facilitate rapid drug
access (see text for details).
doi:10.1371/journal.pone.0064297.g002
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initial experiments it was found that the worm enters the channel
in a random orientation and was only in the correct orientation
(i.e. head first, Fig. 2 D, E, F) 42% of the time. It has previously
been reported that worms preferentially adopt a head orientation
if small pillars are fabricated within such entry channels [10].
These pillars act as obstacles to the worm’s movement towards the
trap. When a constant hydrostatic pressure is applied to the inlet
port, worms escape through this micropillar array in the
appropriate (head-to-tail) orientation. Thus we incorporated
micropillars (50 mm in diameter) into the design of the EPG chip
(Fig. 2C) and this increased the percentage of worms that entered
the channel head first to 71% (of 55 worms tested). The selection
of correctly oriented worms was made using valve 3 (Fig. 2C). If a
worm enters tail-first, it may be flushed away through the
collection outlet by opening this valve.
The device also allows drugs, compounds or chemicals to be
washed on and off the worm while it is trapped in the recording
channel. This was achieved by an additional drug port (Fig. 2C)
used to deliver drugs to the worm. In order to improve drug
delivery to the worm in the trapping channel the chamber was
modified to allow access of the drug along the entire length of the
worm’s body at once. This was done by adding a wide chamber
along one side of the trapping channel as shown in Fig. 2G. This
chamber was separated from the main body of the worm by a
perforated partition punctuated with a row of 10 mm holes. This
improved design allowed the drug to rapidly access the length of
the worm. Videos S1 and S2 compare dye access to the chamber
without and with the perforated partition, respectively. Without
the perforated side chamber the access time was 4665.4 sec,
n = 56 s.d., whilst with the perforations the dye access occurred
within seconds. Furthermore, this design reduced the time
required to wash out the drug.
The device was designed to incorporate integrated electrodes.
Thus it circumvents the need for a separate electrode and allows
for direct connection to the recording amplifier.
Device Fabrication
Devices were fabricated using soft lithography [38] using a two-
step process. Acetate masks (Micro Lithography Services Ltd,
Essex, UK) were used to define large scale features. Masters for
casting PDMS were made from SU8-5 (Chestech, Warwickshire,
UK). To make the device a thin layer of SU8 was spin-coated on a
wafer to make the trapping channel (10 mm thick). Positive resist
(AZ40XT, MicroChemicals GmbH, Germany) was used to form
the flow channel which is 60 mm high. SU8-50 (Chestech,
Warwickshire, UK) was spin-coated on another wafer to provide
the pneumatic control layer (80 mm thick). After exposure of the
resist, the flow layer master was baked at 130uC for 30 seconds to
reflow the resist to form semi-cylindrical flow channels. Before
moulding the PDMS surfaces were treated with trichloro (1H, 1H,
2H, 2H-perfluorooctyl) silane 97% vapour (Sigma-Aldrich). The
channel was made from PDMS (10 part A: 1 part B) to a thickness
of , 5 mm. The control layer was created by spin-coating the
PDMS mixture on the control layer master at 900 rpm for 30
seconds, yielding a thickness of 100 mm. After degassing for 30
minutes and curing at 100uC for 1 hour, the PDMS replicas were
peeled off the masters. Holes for different ports were punched and
cleaned before bonding. After treatment with oxygen plasma
(50 W, 30 s), the PDMS flow layer was bonded onto control layer
with hand alignment. The same process was used to bond them
onto a glass cover slide which acts as the base. Finally, sections of
polythene tubing were attached to the chip ports. Four solenoid
valves (Clippard minimatic, 3-way normally-closed valve) were
used to achieve the external valve control. The inlet is connected
Table 1. A summary of EPG parameters compared for NeuroChip and conventional microelectrode recordings.
Conventional recording NeuroChip
Wild-type (N2) (n = 5)
EPG amplitude (mV) 4.78061.006 4.41060.051
EPG frequency (s21) 0.06060.016 0.07560.019
EPG duration (s) 0.11260.015 0.11660.006
Average number of P waves (pump21) 0.59060.143 1.78860.225***1
‘e’ amplitude (mV) 0.20360.039 0.25760.037
R-E interval (s) 28.97366.863 24.65865.407
R-E ratio 1.00660.097 1.22260.085
Wild-type with 5-HT (10 mM) (n = 10)
EPG amplitude (mV) 7.58060.769 8.37060.835
EPG frequency (s21) 1.87860.120 3.46760.104****2
EPG duration (s) 0.13560.007 0.10160.002***3
Average number of P waves (pump21) 0.20160.087 0.12660.035
‘e’ amplitude (mV) 1.08060.062****4 1.75360.079****5
R-E interval (s) 0.55060.170 0.19860.009
R-E ratio 1.04660.043 1.14360.020
These recordings were made from the same populations of wild-type N2 worms. Data are the mean 6 s.e.mean of recordings from ‘n’ worms. Each parameter was
derived from either AutoEPG analysis of all the EPGs captured in a recording of 5 minutes or, for manual analysis, from 60 EPGs for ‘n’ worms. Comparisons made by
unpaired Student’s t-test to the same parameter for 1conventional wild-type N2 recording without 5-HT (P = 0.001);
2conventional wild-type N2 recording with 5-HT (P,0.0001);
3conventional wild-type N2 recording with 5-HT (P = 0.0002);
4conventional wild-type N2 recording without 5-HT (P,0.0001);
5NeuroChip recording without 5-HT (P,0.0001).
doi:10.1371/journal.pone.0064297.t001
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to an air compressor and the outlet is connected to the NeuroChip.
When an excitation voltage of 6 volts is applied to the solenoid
valve, the solenoid pulls the valve into the open state and the
compressed air pressurizes the micro valve on chip. An I/O board
(Phidgets USB Interface 0/16/16) is connected between the power
supply and solenoid valves, playing the role of physical switches, to
control the on/off states of the valves automatically. The micro-
valves in the bottom layer are driven by software and provide a
semi-automatic means of loading a single worm, recording an
EPG signal, drug delivery and worm unloading.
The three platinum electrodes were fabricated on the glass
substrate, at the entrance of the three fluid ports (Fig. 2B and C).
Holes were drilled through the two PDMS layers to expose the
electrodes to the solution. These integrated electrodes simplify
worm handling and markedly improve the signal to noise ratio
(SNR). The EPG signals recorded from this chip have a SNR
larger than 8, providing the capability for fine resolution of
features in the EPG waveform. All electrodes are connected to a
conventional high-input impedance amplifier. The electrodes
under the worm port and drug port are connected together to
the recording electrode, whilst the electrode in the outlet port is
grounded. The NeuroChip is placed in a Faraday cage.
Operation of the Device
Valves 2, 3 and 4 (V2, V3, and V4 in Fig. 2C) were actuated to
close the bypass channels. The worm was pumped by positive
pressure (0.3 mBar) into the chip from the worm port by
compressed air controlled by the computer. All other ports were at
atmospheric pressure. At this small constant positive pressure, the
worm was pushed into the trapping region (see Fig. 2E).
Electrophysiological signals were then captured and either
observed in real time or recorded for post hoc analysis. If the
worm was in the correct orientation for EPG recording i.e. nose
first, then the experiment was continued. If not, the worm was
rapidly unloaded from the chip (by closing valve 2 and opening
valve 1 and 3). Drugs were applied by closing valve 1 (V1 in
Fig. 2C), and opening valve 2 and 4, thus delivering drugs from the
drug port. To facilitate access of the drug to the worm, valve 4 (the
waste channel) was closed and the drug was allowed to flow into
waste port around the worm. The EPG was then recorded in the
presence of the drug. Drugs can be washed off the worm by closing
valve 2 and opening valve 1. Finally valve 2 and 4 was closed and
valve 1 and 3 opened to unload the worm from the device. This
worm could be collected after EPG recording e.g. for genotyping
by PCR, and the device was then ready to receive the next worm.
Figure 3. An example of an EPG recording collected from the tail and the recovery trapped and released worms. A. An
electrophysiological recording made from the tail of a worm that entered the chamber in the wrong orientation. Note the lack of the features seen
with the EPG waveform compared to Fig. 1C and the small amplitude of the signal. B. Worms can be recovered from the EPG chip following
recording and show normal fecundity and viability. Wild-type (N2) worms that were not trapped in the device (top row, ‘normal’), or trapped and
released (bottom two rows) were followed for development and survival over the course of six days. The worms that had been released from the
device were alive, moved in a similar manner and produced the same number of progeny as untreated worms.
doi:10.1371/journal.pone.0064297.g003
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Worm Culture and Sample Preparation
Wild-type C. elegans (N2, Bristol) and eat-4 mutants (strain
MT6308, eat-4(ky5)III and strain MT6318, eat-4(n2474)III) were
cultured according to standard protocols [39]. Experiments were
performed on age-synchronized worms, either L2 larvae or L4
plus one day old adults. Dent’s saline compound (composition in
mM; D-glucose 10, HEPES 10, NaCl 140, KCl 6, CaCl2 3, MgCl2
1, pH 7.4 with NaOH) was injected into the chip to provide a
liquid environment. The peat-4::ChR2;mRFP integrated line
(described below) was crossed into eat-4 (ky5) to generate a strain
carrying a visual marker, red fluorescent protein, for the eat-4
mutant, as follows: Males carrying the integrated transgene were
produced by heat-shocking L4 hermaphrodites at 30uC for 6
hours. A population of males was maintained by crossing with L4
hermaphrodites from the same line. Young males carrying the
integrated transgene were mated with L4 eat-4(ky5) hermaphro-
dites. In the F1 generation, L4 hermaphrodites expressing mRFP
were picked to individual plates and allowed to self. In the F2
generation, L4 hermaphrodites expressing mRFP were picked to
individual plates and allowed to self. Their progeny, the F3
generation, were screened for plates where all F3 animals
expressed mRFP, i.e., the F2 hermaphrodite was homozygous
for the transgene. This screening was carried out before the first F3
progeny reached the adult stage, allowing the F2 animal from such
plates to be identified and removed for single worm lysis and
genotyping of the eat-4(ky5) allele. Genotyping of the eat-4(ky5), a
613 bp deletion, was carried out by PCR as described below.
Conventional Microelectrode EPG Method
Experiments for recording EPGs from intact worms and cut
heads were performed as previously described [40].
Figure 4. A comparison of basal EPG recordings with conventional microelectrodes and the microfluidic device. Recordings were
made from wild-type worms in the absence of 5-HT and therefore the frequency of the EPGs is low (around 0.1 Hz). A. 5 minutes of conventional
microelectrode recording from intact worm B. 5 minutes of recording using the NeuroChip. Drift in the baseline is probably likely due to residual
movement of the worm in the chamber and can be subtracted with filtering if desired (inset shows signal filtered to remove this drift). Stable EPG
waveforms can be captured for extended periods of time. C. An example of a single EPG waveform recorded using the conventional microelectrode.
D. An example of a single EPG waveform recorded using the NeuroChip. Note the much improved signal to noise ratio in the NeuroChip compared
with a conventional recording. This is due to the fact that often greater suction has to be exerted to secure the freely moving worm on the
microelectrode.
doi:10.1371/journal.pone.0064297.g004
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Single Worm PCR
This was performed to detect the genomic deletion in the
mutant eat-4(ky5). Primers used to amplify over the eat-4(ky-5)
genomic breakpoints were 59-GCTTGTCAGAAGACAAGTGC-
39 and 59-CATATGATCCTGTGAATGC-39. Single worm PCR
was performed according to established protocols [41] using
optimised cycling parameters and Taq polymerase (Qiagen).
Figure 5. 5-HT (serotonin) stimulated worms: comparison of conventional microelectrodes and the microfluidic device. Wild-type
worms that were incubated in 10 mM 5-HT for at least 10 minutes before, and throughout the entire experiment. A. 5 minute trace using a
conventional microelectrode B. 5 minutes trace using the NeuroChip. C. Example of a single EPG waveform recorded using the conventional
microelectrode. D. Example of a single EPG waveform recorded using the NeuroChip. E and F. Time courses of the EPG frequency and EPG duration,
comparing the stability of recording with conventional microelectrode or the NeuroChip. Data are the mean 6 SEM. A higher frequency and shorter
pump duration is observed with NeuroChip compared to conventional recordings, (n = 10). Note that conventional recordings from intact worms
have an improved signal to noise ratio in the presence of 5-HT compared to without 5-HT, Fig. 3 C; Fig. 4C. 5-HT reduces motility [68,69] and so less
suction has to be applied to hold the worms in the recording electrode. Reduced seal resistance is predicted to reduce the noise [33].
doi:10.1371/journal.pone.0064297.g005
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Data Acquisition and Signal Analysis
The NeuroChip was connected to an AxoClamp 2A amplifier
using a x1 headstage (Axon Instruments, USA). Recordings were
acquired using a Digidata 1320 interface and Axoscope software
(Axon Instruments, USA). Axoscope recordings were made for 5
minutes for the comparison of EPG parameters between
conventional and chip recordings, and for 2 minutes for the
screening experiments. They were analysed either manually or
using AutoEPG [31], as indicated. The EPG parameters that were
measured were i) peak to peak amplitude (manually) ii) average
frequency (AutoEPG) iii) the duration of a single EPG waveform
or ‘pump’ measured as the peak E to peak R time interval
(AutoEPG) iv) the interval between consecutive individual pumps
measured as the R to E interval (AutoEPG) v) the average number
of ‘P’ waves per pump (AutoEPG) vi) the average amplitude of ‘e’
(manually by measuring the perpendicular distance of the peak of
the waveform from the baseline of the EPG) vii) the ratio of the
amplitude of ‘R’ to ‘E’, as an overall measure of EPG shape
(AutoEPG). Where indicated in the results, low frequency drift was
removed by Clampfit 9.0 (Axon Instruments) with a Highpass
Bessel filter and 0.5 Hz 230 dB cut-off frequency.
Optogenetics
A strain of C. elegans expressing ChR2 specifically in glutama-
tergic neurones was generated. The method is based on that
previously described for expression of ChR2 in cholinergic
neurones [42]. For expression in glutamatergic neurones, ChR2
was amplified from the plasmid pmyo-3::ChR2(gf)::yfp (provided by
Alexander Gottschalk). ChR2 was amplified using primers that
introduce restriction sites flanking the coding sequence: (from 59-
Figure 6. Optimising drug delivery time. NeuroChip recordings were made from wild-type worms whilst 5-HT (10 mM) was added via the drug
port or outlet port (see Fig. 2C). Two different designs of device were tested. One with (NeuroChip) and one without a wide perforated chamber that
juxtaposed the trapping channel (see Fig. 2G). A. EPG recording taken during exposure to the 5-HT. The red line indicates when the 5-HT was added
to the drug port under a positive pressure of 1 bar. This recording was made using the device with the wide side chamber i.e. NeuroChip B. Response
time to 5-HT for NeuroChip. The red arrow indicates when 5-HT was applied either via the drug port or via the outlet port as indicated. The dotted
black line indicates the response time for the device without the wide side chamber. The blue line indicates the response time for NeuroChip with 5-
HT added directly to the nose via the outlet port. The response to 5-HT in NeuroChip was significantly greater than the response that was recorded
compared to the device without the side chamber (n = 5 worms for each design; data are mean6 SEM; ** P= 0.0089, Student’s t-test for the last time
point). The maximum pump rate following 5-HT application to NeuroChip closely matched that observed in worms that were pre-incubated in 5-HT
prior to addition to the device (see Table 1) suggesting full equilibriation of the drug with the worm. The experiments in which the 5-HT was added to
the nose via the outlet port had to be terminated after 15 minutes as the increased pressure in the channel made it difficult to maintain the worm in
the trap. However, 2 minutes after addition of 5-HT there was a significantly greater increase in frequency when 5-HT was applied to the nose
compared to addition via the drug port (n = 5 worms for each design P= 0.0013, one-way ANOVA) suggesting that the onset of response might be
slightly faster following this route of application.
doi:10.1371/journal.pone.0064297.g006
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Figure 7. Detecting modulatory drug effects with NeuroChip. Wild-type worms in the presence of 10 mM 5-HT were used. Ethanol was
applied through the drug port of NeuroChip. A. An example of the change in the EPG waveform with 400 mM ethanol and (below) a 5 minute
recording showing the time-course of the ethanol effect. The red line indicates the point at which ethanol was added to the drug port. Note the rapid
reduction in EPG frequency. B. Ethanol modulates four parameters of the EPG (red arrows indicate the time of addition of ethanol via the drug port);
n = 3 worms for each graph; data are mean 6 SEM.
doi:10.1371/journal.pone.0064297.g007
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39): ChR2-SpeI-F: CTAGAGACTAGTATGGATTATG-
GAGGCGCCCTG; and ChR2-KpnI-R: ATGGGGTACCt-
taGGGcACCGCGCCAGCCTCGGCCTC. The R primer was
designed to introduce a stop codon at the end of the ChR2 coding
sequence and a synonymous substitution that disrupts the KpnI
site in the 39 end of the ChR2 coding sequence, shown in lowercase
in the primer sequence. mRFP was amplified with the following
primers: (from 59-39): mRFP-AgeI-F CTA GAA CCG GTC AAT
GGC CTC CTC CGA GGA CG and mRFP-EcoRI-R GCA
CTG AAT TCT TAG GCG CCG GTG GAG TGG C. PCR
was carried out according to standard procedures and purified
PCR products were subcloned into pCR-BluntII-TOPO (Invitro-
gen). The fidelity of the DNA amplification was verified by
sequencing (MWG). ChR2 and mRFP were cut out of the TOPO
constructs with SpeI/KpnI and AgeI/EcoRI respectively and
sequentially ligated into a Gateway pENTR backbone. XL-10
Gold cells (Stratagene) were transformed with the ligation product
according to the manufacturer’s instructions. The entry clone
pENTR::ChR2;mRFP was recombined with a Gateway destination
vector containing the promoter region of eat-4, pDESTpeat-4
(pDESTpeat-4 contains the eat-4 promoter region from nucleotide
position 26022 to 21), in an LR recombination reaction
according to the manufacturer’s instructions (Invitrogen) to
produce peat-4::ChR2;mRFP. To generate transgenic lines, an
injection mix containing 16 injection buffer (final concentration
2% polyethylene glycol, molecular weight 6000–8000, 20 mM
potassium phosphate, pH 7.5, 3 mM potassium citrate, pH 7.5),
and peat-4;ChR2;mRFP (50 ng/ml) was injected into the gonads of
wild-type (N2) day old adult C. elegans. Each injected worm was
transferred to a new plate and incubated at 20uC. F1 animals
expressing mRFP were picked to new plates. Lines were
established from plates where expression of mRFP persisted in
the F2 generation. The extrachromosomal array was integrated
into the genome by UV irradiation. 25–30 L4 hermaphrodites
carrying the extrachromosomal array, as determined by visual
confirmation of mRFP expression, were transferred to three
unseeded NGM plates. These plates, with lids removed, were
subjected to a UV dose of 300 J/mz in a Stratagene UV
crosslinker. UV irradiated worms (P0) were transferred to NGM
plates seeded with OP50 approximately 5 worms per plate, and
were incubated at 20uC. 24 hours after exposure, P0 animals were
transferred to fresh seeded plates to ensure that the first progeny of
irradiated animals were not used. On the third and fourth day
after UV exposure, 250 L4 animals from the F1 generation were
picked to individual seeded plates, giving 500 F1 animals. On the
seventh and eighth day after UV exposure, two F2 L4s from each
F1 plate were transferred to individual plates, giving a total of
1000 F2s. The progeny of these F2 animals were screened for
100% transmission of the transgene, determined by expression of
mRFP in the pharyngeal neurons. Following confirmation of
ChR2 activity, integrated lines were backcrossed into N2 six times
to remove background mutations. A single integrated transgenic
line expressing peat-4::ChR2;mRFP was used in the microfluidic
experiments.
ChR2 requires the cofactor retinal for light activation, thus
prior to the experiment L4 worms were incubated overnight either
off (control) or on retinal feeding plates as previously described
[42].
Light illumination was achieved using a narrow bandwidth ultra
bright blue (470 nM) LED (Maplin Electronics) as previously
described [42]. The LED was placed on the top of the trapping
channel in contact with the chip. Individual worms were loaded
into the microfluidic chamber with 2 mM 5-HT to stimulate
pharyngeal pumping. EPG signals were captured 2 minutes
before, 2 minutes during and 2 minutes after LED illumination of
the chamber.
Results
Capture of EPG Signals with NeuroChip
The pharynx of C. elegans consists of a radial muscle which is
divided into three functional parts, the corpus near the mouth of
the nematode, the isthmus (I) in the middle, and the terminal bulb
(TB) (Fig. 2F) [30,43,44]. The integral neural circuit drives and
regulates its activity. An EPG signal corresponds to a single
pumping action from these three parts (a contraction followed by a
relaxation) and a typical EPG signal comprises five phases, called
e, E, P, R and r. These features can readily be resolved in a
conventional microelectrode recording made from a cut head
preparation of C. elegans (Fig. 1A) [27]; removing the head from the
body of the worm improves the stability of the recording. These
phases are generated with each complete pharyngeal muscle
contraction relaxation cycle of wild-type worms. The excitation
phase that drives muscle contraction consists of two positive spikes,
a small one ‘e’ which derives from activity of the cholinergic
pacemaker neurone MC [45] followed by a bigger one ‘E’ which
records the electrical activity that underpins contraction of the
pharynx [27]. The plateau phase contains several negative spikes
‘P’ which correlate with activity of the M3 inhibitory glutamatergic
motor neurons [30]. The ‘R’ or relaxation phase typically
comprises two negative transients, a bigger one ‘R’ resulting from
synchronous repolarisation of the pharyngeal corpus and anterior
isthmus followed by a small one ‘r’ which is due to terminal bulb
repolarisation [27]. ‘E’ and ‘R’ spikes are useful for studying
muscle excitability, and ‘e’ and ‘P’ waves are useful for studying
excitatory and inhibitory synaptic functions, respectively. The
pattern of activity provides information about coordinated activity
in the neural network [31]. The components of the wild-type EPG
signal are shown in Fig. 1A. All the neural features of the EPG can
be seen in the recordings obtained with the new device (Fig. 1C,
far right trace) which we have therefore called NeuroChip. We
made a direct comparison of parameters obtained from conven-
tional microelectrode recordings and NeuroChip which indicate
Table 2. eat-4 mutants recorded with NeuroChip or
conventional microelectrode recordings have the same
phenotype.
Conventional
recording NeuroChip
Eat-4(n2474) (n =5)
EPG frequency (s21) 0.05560.007 0.09060.015
EPG duration (s) 0.28760.014****1 0.17260.009****3
Average number of P waves 0.28060.065*2 0.10360.022****4
‘e’ amplitude (mV) 0.36860.030 0.37660.034
R-E interval (s) 26.51363.078 22.28863.867
R-E ratio 2.17060.117 1.49160.085
Data are the mean 6 s.e.mean of recordings from ‘n’ worms. Each parameter
was derived from AutoEPG analysis of all the EPGs captured in a recording of 5
minutes or, for manual analysis, from 60 EPGs. Eat-4 had increased pump
duration and decreased number of ‘P’ waves compared to wild-type.
Comparisons made by unpaired Student’s t-test to the respective parameters
for 1,2 conventional wild-type N2 recording without 5-HT, P,0.0001 and
P= 0.0208, respectively; or 3,4 to wild-type N2 NeuroChip recording without 5-
HT, P,0.0001. Wild-type data are provided in Table 1.
doi:10.1371/journal.pone.0064297.t002
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that the amplitude, pump duration and waveform (e, E, P, R, r)
are comparable using the two experimental approaches (Table 1).
NeuroChip also captured electrophysiological signals from the tail
of the worm: These recordings had a frequency and duration
indicating they were likely to originate from pharyngeal activity
(Fig. 3A) and are similar to those previously described [33]. They
lack the detail of the EPG recorded from the head. Thus whilst
they may be used to examine gross drug effects on the rate of
pharyngeal pumping [33] they cannot be used to resolve the
activity of different neural components of the pharyngeal circuit.
Worms can be Recovered and Propagated after
NeuroChip Recording
To evaluate whether or not the trapping of the worms in the
microfluidic device caused damage we conducted recovery
experiments in which worms were captured in the channel, EPGs
recorded for five minutes, and the worms then retrieved and
placed back on culture plates. We measured the impact of
trapping on motility by transferring individual worms onto an agar
plate without food and after one hour counting the number of
Figure 8. NeuroChip detection and selection of C. elegansmutants. A population of wild-type worms was spiked the mutant eat-4 (7 N2 wild-
type plus 3 eat-4) and subjected to NeuroChip analysis to select the mutant worms. A. Criteria of EPG pump duration and B. number of ‘P’ waves per
pump that were used for the selection of mutant from wild-type worms. The boundaries of the wild-type phenotype were defined as three times the
standard deviation of the mean for wild-type recordings. Any worm with a mean value lying outside this boundary was identified as a mutant. C.
Example of an EPG recording obtained from wild-type worm and D. from the mutant eat-4(ky5). Note the longer pump duration and absence of P
waves. E. Matching the NeuroChip phenotype to the worm genotype by PCR. Genotyping was by PCR to amplify the eat-4 locus and confirmed
whether or not the worm carried the genomic deletion. ‘E’ and ‘N’ are the reference lanes for eat-4 and wild type, respectively. N1– N7 are worms that
were sorted as wild-type and E1–E3 are worms that were sorted as mutants from the NeuroChip, phenotyped as eat-4. In three of the samples
identified as wild-type the PCR reaction failed (N2, N4 and N5), but in the remaining samples the PCR result confirms the phenotype assigned by the
NeuroChip analysis. There were no false positive or false negative results. The red arrows indicate the corresponding PCR result for the two EPG traces
shown in C and D.
doi:10.1371/journal.pone.0064297.g008
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Figure 9. Interrogation of neural network properties with optogenetics. A C. elegans strain expressing the blue-light activated ion channel
(470 nm) ChR2 in glutamate neurones was used (peat-4::ChR2;mRFP). A. Confocal image of an adult worm (L4+1 day; peat-4::ChR-2;mRFP). Red
fluorescence reports the expression pattern of the light-activated channel ChR2 and shows expression in glutamate neurones of the nervous system.
NeuroChip recordings were made from these worms in the presence of 2 mM 5-HT. Control recordings were made in worms that had not been pre-
treated with retinal, the cofactor for ChR2 activation. B. Illumination (470 nm) of worms that had not been treated with retinal had no effect on EPG
recordings. Light on at 3 min (green line) and off at 6 min (red line). C. EPG recording obtained from a retinal treated worm. Light on at 2 min (green
line) and off at 4.5 min (red line). LED illumination increased the pump rate and decreased the pump duration, which can be observed from single
EPG traces (shown above). D. Pump rate and duration in response to light activation with (red curve) and without (black curve) retinal. Data are the
mean 6 SEM; n = 4. Pump rate was significantly increased following light activation in the retinal treatment group (P,0.001; paired Student’s t-test,
2 min compared to 6 min) and overall pump rate was higher in the retinal treatment group compared to control during light activation (two way
ANOVA; F = 8.03 P = 0.0298 for the retinal treated group compared to control during light activation). Light activation significantly decreased pump
duration in the retinal treatment group (P,0.01 paired Student’s t-test, 2 min compared to 6 min) whilst there was no change in the control group
(P = 0.2261 paired Student’s t-test, 2 min compared to 6 min).
doi:10.1371/journal.pone.0064297.g009
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body bends made in 3 minutes. Control worms were treated in the
same way except they were not trapped in the device prior to
transfer to the agar plate. Trapped and released worms moved
with a frequency of 21.366.4 body bends min21 whilst controls
moved at a frequency of 26.067.2 body bends min21 (n = 3; mean
6 s.d.). Thus trapping caused a small, approximately 20%
reduction in motility. To test whether trapping impacted on a
worm’s ability to grow and reproduce we released trapped worms
onto individual culture plates with food and counted the number
of progeny from each worm. Worms that had been released from
the device were still alive and had a similar growth rate and
propagation compared to un-trapped (‘normal’) worms (Fig. 3B).
(Two days following release from the trap the average brood size
for six worms was 10464; mean 6 s.d. This is similar to the
expected brood size for 2 day old worms [46]). Overall, therefore,
despite a slight reduction in motility, the trapped and released
worms were able to grow and produce viable progeny.
Thus individual worms may be recovered and propagated
following electrophysiological analysis with NeuroChip, an
important consideration for applying this approach for mutant
screens.
NeuroChip Resolves EPG Signals that are Comparable to
Conventional Recordings
In order to validate the utility of the microfluidic device in
comparison to conventional microelectrode recordings, in partic-
ular with respect to resolving discrete neural components of the
waveform, parallel experiments were performed using both
methods on wild-type worms without 5-HT (Fig. 4) and with 5-
HT (Fig. 5; Table 1). 5-HT (10 mM) stimulates pharyngeal
pumping [47–49] and this was observed for both conventional and
NeuroChip recordings. However, in the presence of 5-HT, the
pump rate was greater and the pump duration was less for the
NeuroChip than for conventional recordings (Table 1). An
explanation for this is provided by a recent paper showing that
the pharyngeal pumping rate of worms moving in liquid is
inhibited [50]: Worms in the conventional recording configuration
are still able to move their bodies vigorously, unlike worms trapped
in the NeuroChip thus these latter worms might be expected to
pump at a higher rate. As pharyngeal pumping frequency
increases the pump duration typically decreases [49]. This also
provides an explanation for the slightly lower pump duration
observed with the device. An alternative possibility is that the
pressure exerted to hold the worm in the trapping chamber may
affect pharyngeal pumping in the NeuroChip device.
Detection of Effects on Synaptic Cholinergic Signalling
Previous studies have shown that 5-HT increases signalling from
the cholinergic pacemaker neurone MC [28,49,51] and this
therefore predicts that 5-HT should increase the amplitude of ‘e’.
NeuroChip is able to directly resolve this effect at least as reliably
as conventional microelectrode recordings (Table 1; compare
Fig. 4D with Fig. 5D) and therefore is capable of defining effects
on excitatory cholinergic synaptic transmission. A caveat to this is
that the amplitude of ‘e’ may be affected by the interval between
‘e’ and the larger ‘E’ spike. If this interval becomes briefer then ‘e’
may become superimposed on the ‘E’ spike which would
contribute to an increase in amplitude as measured with the
current approach. Future analyses could be optimised to resolve
this e.g. by extracting the ‘e’ waveform from the ‘E’ spike.
Rapid Application of Compounds and Simultaneous
Electrophysiological Recording
For drug screening and chemical biology it is advantageous to
have the capability to rapidly apply and remove drugs or
chemicals whilst simultaneously capturing the EPG waveform to
monitor the effect on the activity of the neural circuit. Dye
experiments indicate that drug access to the channel of NeuroChip
is very rapid (Video S2). Using NeuroChip we observed responses
to 5-HT that had a latency of 5 min and achieved the maximal
effect (i.e. same pump rate as worms that were pre-exposed to 5-
HT before addition to the chamber) after 15 minutes (Fig. 6 A, B).
The time taken for the full response to 5-HT to develop likely
reflects the time taken for 5-HT to get access to its site of action
inside the worm. We considered that this might be improved if the
device was configured to allow drug to flow across the mouth of
the worm. However, when 5-HT was applied directly to the
mouth of the worm there was no significant overall effect on the
time-course of the response (Fig. 6B).
We also tested the response time to compounds for which there
is evidence that the cuticle does not present a barrier i.e. ethanol
[40] and for which the rate-limiting factor in the response time
would be the time taken for the drug to get access to the recording
chamber. For these experiments the response time was very rapid,
t1/2,2 min, (Fig. 7) supporting the contention that the cuticle does
not present a significant diffusion barrier to ethanol [40]. Ethanol
(400 mM) had a modulatory effect on 5-HT (10 mM) stimulated
pharyngeal pumping causing a decrease in frequency, an increase
in pump duration, a decrease in the number of ‘P’ waves per pump
and a relative reduction in the amplitude of the ‘E’ spike (Fig. 7).
Figure 10. NeuroChip can be modified to record from smaller
size worms. The aperture of the trapping channel was decreased to
accommodate L2 larva stage C. elegans A. Comparison of the sizes
between the adult (one day after L4 larva) and L2 larva. Adult worms are
between 1110–1150 mm whilst L2 are 360–380 mm [56] B. Example of a
trapped adult C. elegans and the recorded EPG signal. C. Example of a
trapped L2 larva C. elegans and the EPG signal. Although the amplitude
of the EPG is smaller, nonetheless each phase and feature can be
resolved in the waveform.
doi:10.1371/journal.pone.0064297.g010
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Detection of Effects on Inhibitory Neurotransmission and
Mutant Sorting
We tested whether or not the microfluidic device could detect
changes in inhibitory neurotransmission. The eat-4 mutant was
chosen for this study as it harbours a loss of function mutation in a
vesicular glutamate transporter and is deficient in inhibitory
glutamatergic signalling [29]. In the pharyngeal system this leads
to loss of signalling through the inhibitory glutamatergic
motorneurone M3 with a concomitant and distinctive loss of the
EPG ‘P’ waves, which result from M3 activity, and a characteristic
lengthening of pump duration [29]. Similar to the comparison
made for wild-type worms (Table 1), for eat-4 the pump frequency
was higher and duration shorter in NeuroChip compared to
conventional recordings, again perhaps reflecting the impact of
constraining worm movement in the microfluidic chamber on
pumping rate [50]. The number of ‘P’ waves per pump and the
R/E ratio was different between conventional and NeuroChip
recordings for eat-4 (Table 2) but the significance of these
differences are unclear. Importantly, a comparison of the data
obtained from the mutant eat-4 (n2474) (Table 2) with that of wild-
type (Table 1) confirmed the capability of NeuroChip to detect
changes in inhibitory neural transmission. As with conventional
recordings, and consistent with published data [29] eat-4 was
shown to have a reduced number of ‘P’ waves and increased pump
duration (Table 1; Table 2).
Genetic screens of C. elegans pharyngeal phenotypes by visually
scoring the activity of the pharynx in intact worms has been of
great utility in identifying novel mutants and providing insight into
gene function [52]. We therefore tested whether or not NeuroChip
provides an opportunity to resolve mutant from wild-type
pharyngeal function. For this we sorted mutant eat-4 worms from
wild-type on the basis of electrophysiological signature. A wild-
type population of worms was spiked with mutant worms, eat-
4(ky5), and a sample was analysed on NeuroChip. EPG signals
were collected from worms loaded from a reservoir and analysed
in real time. For a worm to be identified as ‘wild-type’ it had to
fulfil the criteria of having a pump duration and number of ‘P’
waves per pump within three times the standard deviation of the
mean established for wild-type recordings in the validation
experiment (Fig. 8A and B). Thus any worm that had average
pump duration greater than 0.1445 s and number of ‘P’ waves less
than 0.169 was identified as a mutant i.e. eat-4 (Fig. 8C and D). On
these criteria three worms were identified as eat-4. Subsequent
genotyping by single worm PCR confirmed that all three worms
that were identified as eat-4 by NeuroChip carried the eat-4
mutation i.e. there were no false positives (Fig. 8E). Thus,
NeuroChip is capable of mutant sorting from wild-type worms
based on the electrophysiological signature. To test whether or not
there were false negatives in a NeuroChip mutant screen we
carried out a further analysis using a strain carrying both the eat-4
(ky5) mutation and red fluorescent protein, eat-4(ky5);peat-
4::ChR2;mRFP. This permitted robust discrimination of wild-type
worms from eat-4 worms after mutant selection and screening on
the basis of the absence of red fluorescence. For this experiment 18
wild-type and 13 eat-4 mutants were mixed together and then 20
were randomly transferred to the loading chamber. 17 worms
were recorded head-first in the correct orientation for EPG and of
these 8 were identified as wild-type and 4 as eat-4 on the basis of
EPG signal. Subsequent visual inspection (independent observer,
single blind trial) confirmed this identification as correct. Thus this
screen generated no false negatives. However, a caveat to this is
that the current device cannot phenotype worms that enter the
device tail first. A solution to this would be to carry out an iterative
approach in which worms that entered tail first were collected and
re-applied to the device.
Throughput
When conducting the genetic screen described above we timed
the throughput. In 1 hour 2 min, 15 worms were recorded (total
time taken, from loading reservoir and adding first worm to the
channel to release of the last worm). Of these, three were tail first
and discarded; thus 12 EPGs were recorded in this time period.
The rate-limiting step is the time required to record enough EPG
waveforms in order to delineate a wild-type or mutant signature,
up to 5 minutes depending on the pumping frequency. This
experiment demonstrates an initial capability of a throughput of
12 worms hour21. This is a significant improvement on the
conventional microelectrode recording approach which is slower
because of the need to make the microelectrode, fill it, position it
and manually capture the motile worm. A skilled operator
employing the conventional approach would have a throughput
maximum of about 2 to 4 recordings hour21.
Interrogating Neural Network Properties with
Optogenetics
Optogenetics is a powerful approach for interrogating the
function of neural networks. It deploys genetically encoded light
sensitive ion channels to provide a means of remotely activating
specific neural pathways by light [53] and has previously been
used to activate neural pathways in C. elegans [54] including in the
pharyngeal nervous system [42]. Here we tested whether
NeuroChip could resolve optogenetic modulation of the neural
network mediated via glutamatergic neurone activation. For this
we used a transgenic strain of C. elegans stably expressing
Channelrhodopsin2 (ChR2) exclusively in glutamate neurones
(peat-4::ChR2;mRFP). Worms treated with 5-HT were subjected to
light (470 nm) illumination whilst capturing EPG signals. Control
experiments were conducted in parallel in which the worms were
not treated with retinal, the co-factor for ChR2 activation. A
selective light-dependent decrease in pump duration was observed
in retinal treated worms but not in controls (Fig. 9). This
recapitulates an earlier study which used a photolysable ‘caged’
glutamate compound and observed a light-dependent decrease in
pump duration [30]. The optogenetic approach in combination
with the NeuroChip permitted capture of EPG signals over a long
time course and thus also resolved a concomitant and sustained
increase in pharyngeal frequency following light activation of peat-
4;ChR2;mRFP (Fig. 9D). A neurobiological explanation of this
observation can be provided by previous studies which have
demonstrated a key role for glutamate signalling in shortening the
duration of the pharyngeal contraction-relaxation cycle in the
presence of 5-HT [49]. This suggests that optogenetic activation of
glutamate signalling in the presence of 5-HT may act to shorten
the contraction-relaxation cycle thus permitting the pharynx to
pump at a faster rate. An alternative or additional explanation is
that glutamate may be directly excitatory to the pharynx and this
is supported by observations of glutamate-dependent depolarisa-
tion of pharyngeal muscle from intracellular recordings [55].
NeuroChip can be Modified for Smaller Nematodes
Previous experimental investigations have required EPGs to be
recorded from early developmental stages of C. elegans which are
considerably smaller in size that adult worms [56]. Thus, after
several iterations, we modified the trapping channel in NeuroChip
to an aperture that could capture EPG signals from L2 C. elegans
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larvae (Fig. 10; Video S3). The waveform of these recordings was
similar to those previously described for L1 larvae [56].
Discussion
Electrophysiological recordings from neural circuits with suction
or extracellular electrodes have the advantage that they can
capture a waveform that reports on the activity of a number of
neural components in any given circuit encompassing excitatory,
inhibitory and modulatory signals [27,57–60] and thus provide a
broadly informative route to defining the effect of drugs or
mutations on neural function. Extracellular recordings from the C.
elegans pharyngeal network have been useful in this regard [61] but
C. elegans is a fast-moving nematode and therefore it is not easy to
collect EPG recordings from the whole nematode with the
conventional suction electrode approach [27]. First, it is hard to
trap the worm’s head when it is vigorously swimming. Second,
once the worm is trapped, more suction is required to keep it in
position leading to a noisier signal which requires filtering. Cut
head preparations may be used to overcome this problem but this
is more time-consuming and technically challenging and not
amenable to a high throughput approach. Thus approaches have
been developed to circumvent this by the design of a microfluidic
chamber for intact worm EPG recordings that completely replaces
the need for micromanipulation and a conventional extracellular
microelectrode [32–34]. The microelectrode function is performed
by a trapping chamber, which acts in a similar fashion to classic
sucrose-gap recordings [57]. Here we show that by changing the
shape of the aperture from a square aperture to an opening that
moulds to the shape of the worm’s head, thus more closely
mimicking the way the worm is held in conventional microelec-
trode recording, it is possible to capture a detailed waveform
which can reliably detect components of the EPG which report
neuronal activity. This represents an important development in
this experimental approach as it opens the way for a precise
definition of neuroactive compounds and mutations with synaptic
phenotypes. The properties of the EPG waveform recorded during
basal activity with either the conventional microelectrode or with
NeuroChip were very similar with the exception that the device
resolved more ‘P’ waves per pharyngeal contraction-relaxation
cycle, or ‘pump’ (Table 1). Recordings were also highly
reproducible between worms conferring advantage for the
detection of discrete electrophysiological phenotypes.
The reproducibility of the EPG recording is an important
feature of NeuroChip which we demonstrate confers capability for
sorting worms on the basis of electrophysiological phenotype. This
indicates applicability for mutagenesis screens with the potential to
deliver new biological insight into neural signalling and synaptic
function as has recently been achieved for other imaging based
screens employing C. elegans e.g. [25]. We show that NeuroChip
can be used for selecting mutant worms from a wild-type
population and for recovering viable worms following recordings,
both of which are important properties if this platform is to be
utilised for mutagenesis screens. In this regard the integration of
NeuroChip with a platform for optogenetics adds the capability to
stimulate and record responses due to activation of discrete
components of the neural network and further extends its
capability for neurogenetic investigation.
The activity of the C. elegans pharyngeal circuit is regulated by a
plethora of neurotransmitter receptors and channels which
represent major targets for human medicines and anthelmintic
drugs and through which toxic drug side effects may also occur
[62]. Indeed, the C. elegans pharyngeal preparation has proven a
useful system for characterising the mode of action of anthelmintic
drugs such as ivermectin and emodepside [55,63–65]. Thus
NeuroChip has applications in chemical biology and toxicology
screens. It incorporates a design feature which permits very rapid
drug application thus optimising the device for such chemical
screens. The throughput of the single channel device is 12 worms
hour21 (all in the correct orientation for EPG recording).
Currently operation of the device is optimal with visual inspection
of the worm in the trap so that worms entering tail first may be
identified and future refinement will seek to automate this aspect.
Furthermore, as Lockery et al demonstrate [33] it is possible to
incorporate at least 8 channels on each microfluidic chip and thus
the throughput could readily be increased to ,100 worms per
hour21.
The size of the NeuroChip trapping channel and its opening
dictates the size of the worm that can be captured and recorded.
We have demonstrated that the design can readily be modified to
accommodate L2 larval stages of C. elegans. There are very few
reports of EPG recordings from larval stages, presumably
reflecting the technical challenge of this in the small, highly motile
worms [66]. Thus NeuroChip opens the way for a precise
characterisation of the pharyngeal network in the developing
organism. Furthermore, the dimensions of L2 C. elegans larvae are
in the same order as many species of nematode of interest because
of their relevance to human and animal disease and crop damage.
Thus, by demonstrating the utility of NeuroChip for smaller size
worms we show its potential for recordings from these parasitic
species of medical and economic importance.
NeuroChip also has application in pharmacokinetic studies as it
provides the opportunity to precisely capture the time-course of
drug response and the ability to make comparisons on different
genetic backgrounds which have modified susceptibility to drugs
or chemicals e.g. drug transporter mutants. Such insight is useful
particularly with respect to the emergence of drug resistance in
parasitic nematodes the mechanisms of which may involve
mutations affecting drug transport [67].
There is scope to further increase the throughput by fully
automating the data capture and online extraction of EPG
parameters. In conclusion, NeuroChip delivers a new tool for
sorting worms on the basis of electrophysiological phenotype with
applications in neurotoxicology, drug discovery and neurogenetics.
Supporting Information
Video S1 Rate of access of dye to the prototype device.
Dye was added to the drug port at the time indicated in
the video. This device did not have the wide perforated
side chamber.
(MP4)
Video S2 Rate of access of dye to NeuroChip. Dye was
added to the drug port at the time indicated in the video.
(MP4)
Video S3 Video of trapped L2 C. elegans and accompa-
nying, unfiltered, EPG signal.
(WMV)
Acknowledgments
eat-4 strains were provided by the C. elegansGenetics Center (CGC) which is
funded by NIH Office of Research Infrastructure Programs (P40
OD010440). Gareth Jones (University of Southampton) provided expertise
for the fabrication of micro-valves. Alexander Gottschalk (Johann
Wolfgang Goethe-University Frankfurt) provided pmyo-3::ChR2(gf)::yfp.
Elodie Siney (University of Southampton) conducted C. elegans outcrossing.
Ben Mulcahy and Hans Schuppe (University of Southampton) assisted with
Neurochip for Screening C elegans
PLOS ONE | www.plosone.org 15 May 2013 | Volume 8 | Issue 5 | e64297
confocal imaging. Christopher James, Institute of Digital Healthcare,
University of Warwick, UK provided the AutoEPG software for analysis.
Author Contributions
Conceived and designed the experiments: CH JD JM CM VOC LHD
HM. Performed the experiments: CH JD JK CM. Analyzed the data: CH
JK VOC LHD HM. Wrote the paper: CH JD JK CM VOC LHD HM.
References
1. Shen K, Bargmann CI (2003) The immunoglobulin superfamily protein SYG-1
determines the location of specific synapses in C. elegans. Cell 112: 619–630.
2. Sieburth D, Ch’ng Q, Dybbs M, Tavazoie M, Kennedy S, et al. (2005)
Systematic analysis of genes required for synapse structure and function. Nature
436: 510–517.
3. Chen L, Wang Z, Ghosh-Roy A, Hubert T, Yan D, et al. (2011) Axon
regeneration pathways identified by systematic genetic screening in C. elegans.
Neuron 71: 1043–1057.
4. Chokshi TV, Ben-Yakar A, Chronis N (2009) CO2 and compressive
immobilization of C. elegans on-chip. Lab on a Chip 9: 151–157.
5. Hulme SE, Shevkoplyas SS, Apfeld J, Fontana W, Whitesides GM (2007) A
microfabricated array of clamps for immobilizing and imaging C. elegans. Lab
on a Chip 7: 1515–1523.
6. Zeng F, Rohde CB, Yanik MF (2008) Sub-cellular precision on-chip small-
animal immobilization, multi-photon imaging and femtosecond-laser manipu-
lation. Lab on a Chip 8: 653–656.
7. Krajniak J, Lu H (2010) Long-term high-resolution imaging and culture of C.
elegans in chip-gel hybrid microfluidic device for developmental studies. Lab
on a Chip 10: 1862–1868.
8. Cui X, Lee LM, Heng X, Zhong W, Sternberg PW, et al. (2008) Lensless high-
resolution on-chip optofluidic microscopes for Caenorhabditis elegans and cell
imaging. Proc Natl Acad Sci U S A 105: 10670–10675.
9. Chronis N, Zimmer M, Bargmann CI (2007) Microfluidics for in vivo imaging
of neuronal and behavioral activity in Caenorhabditis elegans. Nature Methods 4:
727–731.
10. Chokshi TV, Bazopoulou D, Chronis N (2010) An automated microfluidic
platform for calcium imaging of chemosensory neurons in Caenorhabditis elegans.
Lab on a Chip 10: 2758–2763.
11. Chalasani SH, Chronis N, Tsunozaki M, Gray JM, Ramot D, et al. (2007)
Dissecting a circuit for olfactory behaviour in Caenorhabditis elegans. Nature 450:
63–70.
12. Lockery SR, Lawton KJ, Doll JC, Faumont S, Coulthard SM, et al. (2008)
Artificial dirt: microfluidic substrates for nematode neurobiology and behavior.
J Neurophysiol 99: 3136–3143.
13. Qin J, Wheeler AR (2007) Maze exploration and learning in C. elegans. Lab
on a Chip 7: 186–192.
14. Park S, Hwang H, Nam SW, Martinez F, Austin RH, et al. (2008) Enhanced
Caenorhabditis elegans locomotion in a structured microfluidic environment. PLoS
One 3: e2550.
15. Shi W, Qin J, Ye N, Lin B (2008) Droplet-based microfluidic system for
individual Caenorhabditis elegans assay. Lab on a Chip 8: 1432–1435.
16. Rezai P, Siddiqui A, Selvaganapathy PR, Gupta BP (2010) Electrotaxis of
Caenorhabditis elegans in a microfluidic environment. Lab on a Chip 10: 220–226.
17. Hulme SE, Shevkoplyas SS, McGuigan AP, Apfeld J, Fontana W, et al. (2010)
Lifespan-on-a-chip: microfluidic chambers for performing lifelong observation of
C. elegans. Lab on a Chip 10: 589–597.
18. Sznitman R, Gupta M, Hager GD, Arratia PE, Sznitman J (2010) Multi-
environment model estimation for motility analysis of Caenorhabditis elegans. PLoS
One 5: e11631.
19. Zimmer M, Gray JM, Pokala N, Chang AJ, Karow DS, et al. (2009) Neurons
detect increases and decreases in oxygen levels using distinct guanylate cyclases.
Neuron 61: 865–879.
20. Rohde CB, Zeng F, Gonzalez-Rubio R, Angel M, Yanik MF (2007) Microfluidic
system for on-chip high-throughput whole-animal sorting and screening at
subcellular resolution. Proc Natl Acad Sci U S A 104: 13891–13895.
21. Crane MM, Chung K, Lu H (2009) Computer-enhanced high-throughput
genetic screens of C. elegans in a microfluidic system. Lab on a Chip 9: 38–40.
22. Stirman JN, Brauner M, Gottschalk A, Lu H (2010) High-throughput study of
synaptic transmission at the neuromuscular junction enabled by optogenetics
and microfluidics. J Neurosci Methods 191: 90–93.
23. Casadevall i Solvas X, Geier FM, Leroi AM, Bundy JG, Edel JB, et al. (2011)
High-throughput age synchronisation of Caenorhabditis elegans. Chem Commun
(Camb) 47: 9801–9803.
24. Johari S, Nock V, Alkaisi MM, Wang W (2012) High-throughput microfluidic
sorting of C. elegans for automated force pattern measurement. Advanced
Materials and Nanotechnology 700: 182–187.
25. Crane MM, Stirman JN, Ou C-Y, Kurshan PT, Rehg JM, et al. (2012)
Autonomous screening of C. elegans identifies genes implicated in synaptogenesis.
Nature Methods 9: 977–980.
26. Jensen M, Hoerndli Fre´de´ric J, Brockie Penelope J, Wang R, Johnson E, et al.
(2012) Wnt signaling regulates acetylcholine receptor translocation and synaptic
plasticity in the adult nervous system. Cell 149: 173–187.
27. Avery L, Raizen D, Lockery S (1995) Electrophysiological methods. Methods
Cell Biol 48: 251–269.
28. Raizen DM, Avery L (1994) Electrical activity and behavior in the pharynx of
Caenorhabditis elegans. Neuron 12: 483–495.
29. Lee RY, Sawin ER, Chalfie M, Horvitz HR, Avery L (1999) EAT-4, a homolog
of a mammalian sodium-dependent inorganic phosphate cotransporter, is
necessary for glutamatergic neurotransmission in Caenorhabditis elegans. J Neurosci
19: 159–167.
30. Li H, Avery L, Denk W, Hess GP (1997) Identification of chemical synapses in
the pharynx of Caenorhabditis elegans. Proc Natl Acad Sci U S A 94: 5912.
31. Dillon J, Andrianakis I, Bull K, Glautier S, O’Connor V, et al. (2009) AutoEPG:
software for the analysis of electrical activity in the microcircuit underpinning
feeding behaviour of Caenorhabditis elegans. PLoS One 4: e8482.
32. Hu C, O’Connor V, Holden-Dye L, Morgan H. (2012) A microfluidic tool for
electrophysiological analysis of C. elegans. British Society for Parasitology Spring
Meeting eConf 2012: p79.
33. Lockery SR, Hulme SE, Roberts WM, Robinson KJ, Laromaine A, et al. (2012)
A microfluidic device for whole-animal drug screening using electrophysiological
measures in the nematode C. elegans. Lab on a Chip 12: 2211–2220.
34. Hu C, O’Connor V, Holden-Dye L, Morgan H (2012) An integrated
microfluidic device for high-throughput electrophysiological analysis of C.
elegans. The 16th International Conference on Miniaturized Systems for
Chemistry and Life Sciences, MicroTAS 2012 Okinawa, Japan eConf 2012:
1441–1443.
35. Studer V, Hang G, Pandolfi A, Ortiz M, Anderson WF, et al. (2004) Scaling
properties of a low-actuation pressure microfluidic valve. J Applied Physics 95:
393.
36. Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR (2000) Monolithic
microfabricated valves and pumps by multilayer soft lithography. Science 288:
113–116.
37. Thorsen T, Maerkl SJ, Quake SR (2002) Microfluidic large-scale integration.
Science 298: 580–584.
38. Xia Y, Whitesides GM (1998) Soft lithography. Annu Rev Mater Sci 28: 153–
184.
39. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
40. Mitchell PH, Bull K, Glautier S, Hopper NA, Holden-Dye L, et al. (2007) The
concentration-dependent effects of ethanol on Caenorhabditis elegans behaviour.
Pharmacogenomics J 7: 411–417.
41. Williams BD, Schrank B, Huynh C, Shownkeen R, Waterston RH (1992) A
genetic mapping system in Caenorhabditis elegans based on polymorphic sequence-
tagged sites. Genetics 131: 609–624.
42. Franks CJ, Murray C, Ogden D, O’Connor V, Holden-Dye L (2009) A
comparison of electrically evoked and channel rhodopsin-evoked postsynaptic
potentials in the pharyngeal system of Caenorhabditis elegans. Invert Neurosci 9:
43–56.
43. Albertson DG, Thomson J (1976) The pharynx of Caenorhabditis elegans. Philos
Trans R Soc Lond B Biol Sci 275: 299–325.
44. Pilon M, Mo¨rck C (2005) Development of Caenorhabditis elegans pharynx, with
emphasis on its nervous system. Acta Pharmacol Sin 26: 396–404.
45. Raizen DM, Lee RY, Avery L (1995) Interacting genes required for pharyngeal
excitation by motor neuron MC in Caenorhabditis elegans. Genetics 141: 1365–
1382.
46. Keating CD, Kriek N, Daniels M, Ashcroft NR, Hopper NA, et al. (2003)
Whole-Genome analysis of 60 G protein-coupled receptors in Caenorhabditis
elegans by gene knockout with RNAi. Curr Biol 13: 1715–1720.
47. Avery L, Horvitz HR (1990) Effects of starvation and neuroactive drugs on
feeding in Caenorhabditis elegans. J Exp Zool 253: 263–270.
48. Rogers CM, Franks CJ, Walker RJ, Burke JF, Holden-Dye L (2001) Regulation
of the pharynx of Caenorhabditis elegans by 5-HT, octopamine, and FMRFamide-
like neuropeptides. J Neurobiol 49: 235–244.
49. Niacaris T, Avery L (2003) Serotonin regulates repolarization of the C. elegans
pharyngeal muscle. J Exp Biol 206: 223–231.
50. Vidal-Gadea AG, Davis S, Becker L, Pierce-Shimomura JT (2012) Coordination
of behavioral hierarchies during environmental transitions in Caenorhabditis
elegans. Worm 1: 5–11.
51. Song BM, Avery L (2012) Serotonin activates overall feeding by activating two
separate neural pathways in Caenorhabditis elegans. J Neurosci 32: 1920–1931.
52. Avery L (1993) The genetics of feeding in Caenorhabditis elegans. Genetics 133:
897–917.
53. Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, et al. (2007) Multimodal
fast optical interrogation of neural circuitry. Nature 446: 633–639.
54. Nagel G, Brauner M, Liewald JF, Adeishvili N, Bamberg E, et al. (2005) Light
activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers
rapid behavioral responses. Curr Biol 15: 2279–2284.
55. Pemberton DJ, Franks CJ, Walker RJ, Holden-Dye L (2001) Characterization of
glutamate-gated chloride channels in the pharynx of wild-type and mutant
Neurochip for Screening C elegans
PLOS ONE | www.plosone.org 16 May 2013 | Volume 8 | Issue 5 | e64297
Caenorhabditis elegans delineates the role of the subunit GluCl-alpha2 in the
function of the native receptor. Mol Pharmacol 59: 1037–1043.
56. Hall DH, Altun ZF (2008) C. elegans atlas: Cold Spring Harbor Laboratory Press.
57. Lees GM, Wallis DI (1974) Hyperpolarization of rabbit superior cervical
ganglion cells due to activity of an electrogenic sodium pump. Br J Pharmacol
50: 79–93.
58. Steward O, White CW, Cotman CW, Lynch G (1976) Potentiation of excitatory
synaptic transmission in the normal and in the reinnervated dentate gyrus of the
rat. Exp Brain Res 26: 423–441.
59. Heinzel HG, Weimann JM, Marder E (1993) The behavioral repertoire of the
gastric mill in the crab, Cancer pagurus: an in situ endoscopic and electrophys-
iological examination. J Neurosci 13: 1793–1803.
60. Cook A, Franks CJ, Holden-Dye L (2006) Electrophysiological recordings from
the pharynx. In: The C. elegans community, editors Wormbook: 1–7.
61. Franks CJ, Holden-Dye L, Bull K, Luedtke S, Walker RJ (2006) Anatomy,
physiology and pharmacology of Caenorhabditis elegans pharynx: a model to define
gene function in a simple neural system. Invert Neurosci 6: 105–122.
62. Jones AK, Buckingham SD, Sattelle DB (2005) Chemistry-to-gene screens in
Caenorhabditis elegans. Nat Rev Drug Discov 4: 321–330.
63. Crisford A, Murray C, O’Connor V, Edwards RJ, Kruger N, et al. (2011)
Selective toxicity of the anthelmintic emodepside revealed by heterologous
expression of human KCNMA1 in Caenorhabditis elegans. Mol Pharmacol 79:
1031–1043.
64. Dent JA, Davis MW, Avery L (1997) avr-15 encodes a chloride channel subunit
that mediates inhibitory glutamatergic neurotransmission and ivermectin
sensitivity in Caenorhabditis elegans. EMBO J 16: 5867–5879.
65. Willson J, Amliwala K, Davis A, Cook A, Cuttle MF, et al. (2004) Latrotoxin
receptor signaling engages the UNC-13-dependent vesicle-priming pathway in
C. elegans. Curr Biol 14: 1374–1379.
66. Norman KR, Fazzio RT, Mellem JE, Espelt MV, Strange K, et al. (2005) The
Rho/Rac-family guanine nucleotide exchange factor VAV-1 regulates rhythmic
Behaviors in C. elegans. Cell 123: 119–132.
67. Yan R, Urdaneta-Marquez L, Keller K, James CE, Davey MW, et al. (2012)
The role of several ABC transporter genes in ivermectin resistance in
Caenorhabditis elegans. Vet Parasitol 190: 519–529.
68. Segalat L, Elkes DA, Kaplan JM (1995) Modulation of serotonin-controlled
behaviors by Go in Caenorhabditis elegans. Science 267: 1648–1651.
69. Horvitz HR, Chalfie M, Trent C, Sulston JE, Evans PD (1982) Serotonin and
octopamine in the nematode Caenorhabditis elegans. Science 216: 1012–1014.
Neurochip for Screening C elegans
PLOS ONE | www.plosone.org 17 May 2013 | Volume 8 | Issue 5 | e64297
